LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 1476 | 4222 | 3772 | 1.1193 | 1.1735 |
MCF7 | NU7441 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4252 | 4267 | 0.9971 | 0.9971 |
MCF7 | PD173074 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4512 | 4056 | 1.1128 | 1.1288 |
MDA-MB-231 | Sirolimus | 0.04 | uM | LJP6 | 72 | hr | 868 | 2868 | 3556 | 0.8076 | 0.8006 |
MCF7 | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4831 | 4267 | 1.1327 | 1.1447 |
MCF7 | QL-X-138 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 1814 | 4056 | 0.4463 | 0.2452 |
SK-BR-3 | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 1476 | 2870 | 3772 | 0.7610 | 0.6344 |
MCF7 | OSI-027 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3766 | 4056 | 0.9282 | 0.9145 |
MCF7 | PF431396 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3176 | 4267 | 0.7446 | 0.6959 |
MCF7 | XMD11-50 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3637 | 4056 | 0.8968 | 0.8765 |
MCF7 | Vemurafenib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4219 | 4267 | 0.9908 | 0.9890 |
MCF7 | WZ-4-145 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3090 | 4056 | 0.7619 | 0.7066 |
MCF7 | TWS119 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4758 | 4267 | 1.1141 | 1.1229 |
MCF7 | WYE-125132 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 1763 | 4056 | 0.4347 | 0.2305 |
MCF7 | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3325 | 4267 | 0.7794 | 0.7387 |
MCF7 | PF477736 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 2602 | 4267 | 0.6100 | 0.5168 |
MCF7 | HG-6-64-01 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4834 | 4056 | 1.1918 | 1.2152 |
MCF7 | Y39983 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4249 | 4056 | 1.0481 | 1.0557 |
SK-BR-3 | A443654 | 0.04 | uM | LJP6 | 72 | hr | 1476 | 1173 | 3643 | 0.3221 | -0.1636 |
MCF7 | Barasertib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 1732 | 4267 | 0.4070 | 0.2085 |
MCF7 | Pelitinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4756 | 4267 | 1.1142 | 1.1242 |
MCF7 | AZD8330 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 1989 | 4267 | 0.4666 | 0.3050 |
MCF7 | LDN-193189 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4794 | 4267 | 1.1222 | 1.1302 |
MDA-MB-231 | WYE-125132 | 0.04 | uM | LJP6 | 72 | hr | 868 | 2273 | 3556 | 0.6400 | 0.6059 |
MDA-MB-231 | OSI-027 | 0.04 | uM | LJP6 | 72 | hr | 868 | 3680 | 3556 | 1.0362 | 1.0355 |